Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $91.00 by Analysts at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its target price cut by Barclays from $100.00 to $91.00 in a research note issued to investors on Thursday morning, Benzinga reports. They currently have an overweight rating on the stock.

Other equities analysts also recently issued research reports about the stock. TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. Mizuho boosted their price target on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a neutral rating in a research report on Wednesday, March 6th. TD Cowen increased their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a research report on Friday, March 1st. Royal Bank of Canada reaffirmed an outperform rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. Finally, Stephens raised Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price objective for the company in a research report on Friday, January 5th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus target price of $88.89.

Acadia Healthcare Trading Down 0.9 %

Shares of Acadia Healthcare stock opened at $66.12 on Thursday. The firm’s 50 day moving average is $76.77 and its 200 day moving average is $77.52. The firm has a market capitalization of $6.11 billion, a PE ratio of -472.25, a price-to-earnings-growth ratio of 1.95 and a beta of 1.31. Acadia Healthcare has a 1 year low of $64.74 and a 1 year high of $87.77. The company has a current ratio of 1.27, a quick ratio of 0.67 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. Acadia Healthcare’s revenue was up 9.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. Equities research analysts forecast that Acadia Healthcare will post 3.56 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Quent Capital LLC increased its holdings in Acadia Healthcare by 8.1% during the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after purchasing an additional 284 shares in the last quarter. BNP Paribas Financial Markets boosted its position in shares of Acadia Healthcare by 77.1% during the first quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock valued at $1,700,000 after buying an additional 9,342 shares during the last quarter. Peterson Wealth Services bought a new stake in Acadia Healthcare during the first quarter worth $2,739,000. Retirement Systems of Alabama raised its position in Acadia Healthcare by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock valued at $9,174,000 after buying an additional 303 shares during the last quarter. Finally, OFI Invest Asset Management lifted its stake in Acadia Healthcare by 2.5% during the 1st quarter. OFI Invest Asset Management now owns 164,427 shares of the company’s stock valued at $12,061,000 after acquiring an additional 4,013 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.